Animal model demonstrates role for metabolic enzyme in acute myeloid leukemia

In recent years, mutant IDH proteins have been proposed as attractive drug targets for acute myeloid leukemia. Investigators from Beth Israel Deaconess Medical Center have developed a new animal model that supports IDH2 as a therapeutic target for this widespread blood cancer.

Fuente : http://www.eurekalert.org/pub_releases/2014-01/bid…


Hacer un comentario